Trial Profile
Everolimus in tuberous sclerosis patients with intractable epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Epilepsy; Tuberous sclerosis
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2015 New trial record